Headline News about Astrazeneca Plc ADR
AstraZeneca's Imfinzi Combo Scores FDA Approval For Liver Cancer
October 24, 2022
Via Benzinga
Via Benzinga
PhaseBio Might Have To Return Global Rights To Its Lead Program
September 28, 2022
Via Benzinga
Japan Approves AstraZeneca's Two Treatments For Asthma, Rare Form Of Cancer
September 27, 2022
Via Benzinga
Via Benzinga
Why Are LogicBio Therapeutics Shares Skyrocketing Today?
October 03, 2022
Via Benzinga
Via Benzinga
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions. |
|